Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
900.73%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.79Close
$ 1.15 - $ 5.82 52-Week Range
Ticker Information
Ticker
HUMACompany Name
HUMACYTE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQHUMACYTE INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
HUMA - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 7.37M | 900.73% | $ 818K |
| 3/31/2025 | $ 7.29M | 1409.09% | $ 517K |
| 12/31/2024 | $ 7.24M | 0% | $ 0 |
| 9/30/2024 | $ 7.27M | 0% | $ 0 |
| 6/30/2024 | $ 7.29M | 0% | $ 0 |
| 3/31/2024 | $ 7.49M | 0% | $ 0 |
| 12/31/2023 | $ 7.77M | 0% | $ 0 |
| 9/30/2023 | $ 8.05M | 0% | $ 0 |
| 6/30/2023 | $ 8.25M | 26619.35% | $ 31K |
| 3/31/2023 | $ 8.29M | 622.3% | $ 1.33M |
Key Performance Insights, Last 5 Years
- HUMACYTE INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, HUMACYTE INC's average DepAmor % has been 3015.92%.
- The median DepAmor % for HUMACYTE INC during this period was 615.51%
- HUMACYTE INC reached its highest DepAmor % over the past 5 years at 26619.35%.
- The lowest DepAmor % recorded by HUMACYTE INC in the same timeframe 420.54%
HUMACYTE INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for HUMACYTE INC is calculated as follows: DepAmor [ $ 0 ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] HUMA - Depreciation and Amortization Margin, Last 5 years
420.54%
Minimum
Jun 30, 2022
26619.35%
Maximum
Jun 30, 2023
3015.92%
Average
615.51%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |